SLAS2017 Scientific Program Committee
Conference Chairs
Marcie Glicksman, Ph.D
ORIG3N
Dana Vanderwall
Bristol-Myers Squibb
Advances in Bioanalytics, Biomarkers and Diagnostics:
Track Chair:
Dieter Drexler, Bristol-Myers Squibb
Dieter Drexler, Bristol-Myers Squibb
Associate Track Chair:
Melanie Leveridge, GlaxoSmithKline
Melanie Leveridge, GlaxoSmithKline
Assay Development & Screening:
Track Chair:
Cathy Tralau-Stewart, University of California, San Francisco
Cathy Tralau-Stewart, University of California, San Francisco
Associate Track Chair:
Ed Ainscow, Carrick Therapeutics
Ed Ainscow, Carrick Therapeutics
Automation and High Throughput Technologies:
Track Chair:
Craig Schulz, Amgen
Craig Schulz, Amgen
Associate Track Chair:
Taosheng Chen, St. Jude Children's Research Hospital
Taosheng Chen, St. Jude Children's Research Hospital
Cellular Technologies:
Track Chair:
John Doench, Broad Institute
John Doench, Broad Institute
Associate Track Chair:
Benjamin Haley, Genentech
Benjamin Haley, Genentech
Drug Target Strategies:
Track Chair:
David Swinney, Institute for Rare and Neglected Diseases Drug Discovery
David Swinney, Institute for Rare and Neglected Diseases Drug Discovery
Associate Track Chair:
Chun-wa Chung, GlaxoSmithKline
Chun-wa Chung, GlaxoSmithKline
Data Analysis and Informatics:
Track Chair:
Lenny Teytelman, Protocols.io
Lenny Teytelman, Protocols.io
Associate Track Chair:
Margaret DiFilippo, Dotmatics
Margaret DiFilippo, Dotmatics
Micro- and Nanotechnologies:
Track Chair:
Sindy Tang, Stanford University
Sindy Tang, Stanford University
Associate Track Chair:
Andrew deMello, Institute for Chemical and Bioengineering
Andrew deMello, Institute for Chemical and Bioengineering
